Nan Hee Kim
KOREA University Asan Hospital in Korea · Department of Endocrinology and Metabolism, Korea University Ansan Hospital
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Nan Hee Kim as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 04:00 UTC. Open this list on ClinicalTrials.gov
- Ph2NCT06712615 · Phase II Study of PG-102(MG12) Compared With Placebo in Obesity and Type 2 DiabetesProGen. Co., Ltd. · active not recruiting · Type 2 Diabetes Mellitus (T2DM), Obesity Type 2 Diabetes Mellitus · principal investigator
- N/ANCT02028585 · Effects of Low Fat Milk Consumption on Metabolic SyndromeMinistry of Food and Drug Safety, Korea · completed · Metabolic Syndrome · principal investigator
- N/ANCT02023749 · Effects of Nut Consumption on Metabolic SyndromeMinistry of Food and Drug Safety, Korea · completed · Metabolic Syndrome · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 04:00 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. 4 other NIH projects list an investigator with the same name at a different institution and are left out. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-12 04:00 UTC. The ranking covers the 200 most relevant of 89 PubMed records, and a shared surname and initials can bring in a namesake. All 89 on PubMed
- 1,071 citationsRCR 37.1
- The effect of therapeutic drug monitoring on safety and efficacy of voriconazole in invasive fungal infections: a randomized controlled trial.Clin Infect Dis · 2012317 citationsRCR 13.4
- Riociguat for the treatment of chronic thromboembolic pulmonary hypertension: a long-term extension study (CHEST-2).Eur Respir J · 2015257 citationsRCR 10.4
- Macitentan for the treatment of inoperable chronic thromboembolic pulmonary hypertension (MERIT-1): results from the multicentre, phase 2, randomised, double-blind, placebo-controlled study.Lancet Respir Med · 2017200 citationsRCR 9.0
- 157 citationsRCR 12.5
- Macitentan for the treatment of portopulmonary hypertension (PORTICO): a multicentre, randomised, double-blind, placebo-controlled, phase 4 trial.Lancet Respir Med · 2019144 citationsRCR 6.7
- Unilateral versus bilateral pedicle screw fixation in lumbar spinal fusion.Spine (Phila Pa 1976) · 2000122 citationsRCR 6.9
- Predictors of long-term outcomes in patients treated with riociguat for chronic thromboembolic pulmonary hypertension: data from the CHEST-2 open-label, randomised, long-term extension trial.Lancet Respir Med · 2016121 citationsRCR 5.2
- Effects of green tea consumption on inflammation, insulin resistance and pulse wave velocity in type 2 diabetes patients.Diabetes Res Clin Pract · 2006112 citationsRCR 3.6
- The beneficial effect of high loading dose of rosuvastatin before percutaneous coronary intervention in patients with acute coronary syndrome.Int J Cardiol · 200988 citationsRCR 2.2